ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 65 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,000 | -64.3% | 1,500 | 0.0% | 0.00% | – |
| Q1 2017 | $14,000 | +16.7% | 1,500 | 0.0% | 0.00% | – |
| Q4 2016 | $12,000 | -29.4% | 1,500 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | -5.6% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $18,000 | +20.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | -55.9% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $34,000 | +36.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $25,000 | -26.5% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $34,000 | -12.8% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $39,000 | +18.2% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $33,000 | +17.9% | 1,500 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $28,000 | -20.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $35,000 | -30.0% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $50,000 | +13.6% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $44,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 825,647 | $19,238,000 | 3.04% |
| SECTORAL ASSET MANAGEMENT INC | 1,392,485 | $32,445,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,000 | $1,748,000 | 0.43% |
| Eventide Asset Management | 52,800 | $1,230,000 | 0.17% |
| Alyeska Investment Group, L.P. | 250,434 | $5,835,000 | 0.13% |
| Convergence Investment Partners, LLC | 28,715 | $669,000 | 0.09% |
| COLUMBUS CIRCLE INVESTORS | 253,348 | $5,903,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 66,800 | $1,557,000 | 0.04% |
| Visium Asset Management, LP | 75,001 | $1,748,000 | 0.03% |
| Hodges Capital Management Inc. | 15,000 | $349,000 | 0.02% |